The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Life expectancy and cause of death in males and females with Fabry disease: Findings from the Fabry Registry
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Prevalence of lysosomal storage disorders
Meikle, P. J. (1999) · JAMA · doi:10.1001/jama.281.3.249 · Cited by 2,197
Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
Eng, C. M., Guffon, N., Wilcox, W. R., Germain, D. P., Lee, P., Waldek, S., Caplan, L., Linthorst, G. E., & Desnick, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450102 · Cited by 1,559
Self-citationEnzyme Replacement Therapy in Fabry Disease: A Randomized Controlled Trial
Schiffmann, R., Kopp, J. B., Austin III, H. A., Sabnis, S., Moore, D. F., Weibel, T., Balow, J. E., & Brady, R. O. (2001) · JAMA · doi:10.1001/jama.285.21.2743 · Cited by 1,302
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
Mehta, A., Ricci, R., Widmer, U., Dehout, F., Garcia de Lorenzo, A., Kampmann, C., Linhart, A., Sunder‐Plassmann, G., Ries, M., & Beck, M. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01309.x · Cited by 848
Statistical Analysis of Epidemiologic Data
Selvin, S. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195172805.001.0001 · Cited by 822
MacDermot, K. D., Holmes, A., & Miners, A. H. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.11.769 · Cited by 681
α-Galactosidase A deficiency. Fabry disease
Desnick, R. J. (2001) · Cited by 605
Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy
Sachdev, B., Takenaka, T., Teraguchi, H., Tei, C., Lee, P., McKenna, W. J., & Elliott, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000012626.81324.38 · Cited by 570
Self-citationAgalsidase-Beta Therapy for Advanced Fabry Disease: A Randomized Trial
Banikazemi, M., Bultas, J., Waldek, S., Wilcox, W. R., Whitley, C. B., McDonald, M., Finkel, R., Packman, S., Bichet, D. G., Warnock, D. G., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00148 · Cited by 569
Self-citationFemales with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry
Wilcox, W. R., Oliveira, J. P., Hopkin, R. J., Ortiz, A., Banikazemi, M., Feldt-Rasmussen, U., Sims, K., Waldek, S., Pastores, G. M., Lee, P., et al. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.09.013 · Cited by 544
Self-citationWeidemann, F., Niemann, M., Breunig, F., Herrmann, S., Beer, M., Störk, S., Voelker, W., Ertl, G., Wanner, C., & Strotmann, J. (2009) · Circulation · doi:10.1161/circulationaha.108.794529 · Cited by 488
BRANTON, M. H., SCHIFFMANN, R., SABNIS, S. G., MURRAY, G. J., QUIRK, J. M., ALTARESCU, G., GOLDFARB, L., BRADY, R. O., BALOW, J. E., AUSTIN, H. A., et al. (2002) · Medicine · doi:10.1097/00005792-200203000-00003 · Cited by 461
Germain, D. P., Waldek, S., Banikazemi, M., Bushinsky, D. A., Charrow, J., Desnick, R. J., Lee, P., Loew, T., Vedder, A. C., Abichandani, R., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080816 · Cited by 438
Self-citationFabry disease: Guidelines for the evaluation and management of multi-organ system involvement
Eng, C. M., Germain, D. P., Banikazemi, M., Warnock, D. G., Wanner, C., Hopkin, R. J., Bultas, J., Lee, P., Sims, K., Brodie, S. E., et al. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000237866.70357.c6 · Cited by 411
Self-citationLong-Term Safety and Efficacy of Enzyme Replacement Therapyfor Fabry Disease
Wilcox, W. R., for the International Fabry Disease Study Group, Banikazemi, M., Guffon, N., Waldek, S., Lee, P., Linthorst, G. E., Desnick, R. J., & Germain, D. P. (2004) · The American Journal of Human Genetics · doi:10.1086/422366 · Cited by 404
Self-citationEng, C. M., Banikazemi, M., Gordon, R. E., Goldman, M., Phelps, R., Kim, L., Gass, A., Winston, J., Dikman, S., Fallon, J. T., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318809 · Cited by 385
Self-citationDeaths: Final Data for 2003: (518032006-001)
Hoyert, D. L., Heron, M. P., Murphy, S. L., & Kung, H.-C. (2006) · PsycEXTRA Dataset · doi:10.1037/e518032006-001 · Cited by 362
Sims, K., Politei, J., Banikazemi, M., & Lee, P. (2009) · Stroke · doi:10.1161/strokeaha.108.526293 · Cited by 342
Self-citationHughes, D. A., Elliott, P. M., Shah, J., Zuckerman, J., Coghlan, G., Brookes, J., & Mehta, A. B. (2008) · Heart · doi:10.1136/hrt.2006.104026 · Cited by 318
Natural course of Fabry disease: changing pattern of causes of death in FOS – Fabry Outcome Survey
Mehta, A., Clarke, J. T. R., Giugliani, R., Elliott, P., Linhart, A., Beck, M., & Sunder-Plassmann, G. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.065904 · Cited by 309
Wang, R. Y., Lelis, A., Mirocha, J., & Wilcox, W. R. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31802d8321 · Cited by 305
Prevalence of Fabry Disease in a Cohort of 508 Unrelated Patients With Hypertrophic Cardiomyopathy
Monserrat, L., Gimeno-Blanes, J. R., Marín, F., Hermida-Prieto, M., García-Honrubia, A., Pérez, I., Fernández, X., de Nicolas, R., de la Morena, G., Payá, E., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.062 · Cited by 291
Cardiovascular Disease and Subsequent Kidney Disease
Elsayed, E. F., Tighiouart, H., Griffith, J., Kurth, T., Levey, A. S., Salem, D., Sarnak, M. J., & Weiner, D. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.11.1130 · Cited by 255
Inflammation and cardiovascular risk in dialysis patients
Wanner, C., Zimmermann, J., Schwedler, S., & Metzger, T. (2002) · Kidney International · doi:10.1046/j.1523-1755.61.s80.18.x · Cited by 251
Ries, M., Gupta, S., Moore, D. F., Sachdev, V., Quirk, J. M., Murray, G. J., Rosing, D. R., Robinson, C., Schaefer, E., Gal, A., et al. (2005) · Pediatrics · doi:10.1542/peds.2004-1678 · Cited by 209
ANGIOKERATOMA CORPORIS DIFFUSUM<subtitle>A Clinical Study of Eight Affected Families</subtitle>
(1962) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a066964 · Cited by 183
The Dutch Fabry cohort: Diversity of clinical manifestations and Gb3 levels
Vedder, A. C., Linthorst, G. E., van Breemen, M. J., Groener, J. E. M., Bemelman, F. J., Strijland, A., Mannens, M. M. A. M., Aerts, J. M. F. G., & Hollak, C. E. M. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0484-8 · Cited by 180
Agalsidase Alfa and Kidney Dysfunction in Fabry Disease
West, M., Nicholls, K., Mehta, A., Clarke, J. T. R., Steiner, R., Beck, M., Barshop, B. A., Rhead, W., Mensah, R., Ries, M., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080870 · Cited by 162
Cardiovascular disease after renal transplantation
Dimény, E. (2002) · Kidney International · doi:10.1046/j.1523-1755.61.s80.14.x · Cited by 79
Myofilament Degradation and Dysfunction of Human Cardiomyocytes in Fabry Disease
Chimenti, C., Hamdani, N., Boontje, N. M., COBELLI, F. D., Esposito, A., Bronzwaer, J. G. F., Stienen, G. J. M., Russo, M. A., Paulus, W. J., Frustaci, A., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070576 · Cited by 67
Cited by
Fabry disease revisited: Management and treatment recommendations for adult patients
Ortiz, A., Germain, D. P., Desnick, R. J., Politei, J., Mauer, M., Burlina, A., Eng, C., Hopkin, R. J., Laney, D., Linhart, A., et al. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.02.014 · Cited by 650
Self-citationTreatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
Germain, D. P., Hughes, D. A., Nicholls, K., Bichet, D. G., Giugliani, R., Wilcox, W. R., Feliciani, C., Shankar, S. P., Ezgu, F., Amartino, H., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510198 · Cited by 555
Self-citationHughes, D. A., Nicholls, K., Shankar, S. P., Sunder-Plassmann, G., Koeller, D., Nedd, K., Vockley, G., Hamazaki, T., Lachmann, R., Ohashi, T., et al. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104178 · Cited by 386
Metadata
- Authors
- Waldek, S., Patel, M. R., Banikazemi, M., Lemay, R., & Lee, P.
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 11
- Issue
- 11
- Pages
- 790-796
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W2043841576
- Cited by
- 353
- References
- 31
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.